Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in IMVT — Immunovant, Inc.

CIK 80255 BALTIMORE, MD
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$70,479,460
+$62,043,623 QoQ
Shares Held
1,829,210
+438.6% QoQ
Ownership
0.886%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 226 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. IMVT ranks #60 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in IMVT

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $70,479,460 1,829,210
2026-03-31 $8,435,837 339,607
2025-12-31 $22,701,483 893,056
2025-09-30 $3,297,893 204,584
2025-06-30 $977,824 61,114
2025-03-31 $12,724,256 744,544
2024-12-31 $22,695,511 916,250
2024-09-30 $34,469,901 1,209,046
2024-06-30 $35,947,533 1,361,649
2024-03-31 $60,162,608 1,862,043
2023-12-31 $67,515,936 1,602,562
2023-09-30 $28,026,311 730,042
2023-06-30 $370,446 19,528
2023-03-31 $6,874,093 443,204
2022-12-31 $4,898,981 275,999
2021-09-30 $197,089 22,680
2021-06-30 $186,063 17,603
2021-03-31 $276,818 17,258
2020-12-31 $13,394,545 289,988
2020-09-30 $7,233,304 205,550